Jane Street Group LLC Sells 31,516 Shares of Paragon 28, Inc. (NYSE:FNA)

Jane Street Group LLC lessened its position in Paragon 28, Inc. (NYSE:FNA) by 52.6% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 28,392 shares of the company’s stock after selling 31,516 shares during the period. Jane Street Group LLC’s holdings in Paragon 28 were worth $190,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Intech Investment Management LLC bought a new stake in shares of Paragon 28 during the third quarter valued at about $70,000. Ballentine Partners LLC bought a new stake in Paragon 28 in the third quarter worth $91,000. Creative Planning bought a new position in Paragon 28 during the 3rd quarter worth approximately $91,000. Hsbc Holdings PLC bought a new position in shares of Paragon 28 in the second quarter worth approximately $104,000. Finally, Commerce Bank increased its position in shares of Paragon 28 by 28.5% in the third quarter. Commerce Bank now owns 18,350 shares of the company’s stock valued at $123,000 after acquiring an additional 4,075 shares during the period. Institutional investors own 63.57% of the company’s stock.

Paragon 28 Trading Up 0.5 %

Shares of FNA stock opened at $10.40 on Monday. The stock has a market capitalization of $870.69 million, a P/E ratio of -14.05 and a beta of 1.50. The company has a current ratio of 3.50, a quick ratio of 1.60 and a debt-to-equity ratio of 0.79. The firm’s 50 day moving average is $9.80 and its 200 day moving average is $7.99. Paragon 28, Inc. has a 12-month low of $4.65 and a 12-month high of $14.79.

Paragon 28 (NYSE:FNA) last issued its quarterly earnings results on Tuesday, November 12th. The company reported ($0.15) earnings per share for the quarter, topping the consensus estimate of ($0.16) by $0.01. Paragon 28 had a negative net margin of 25.31% and a negative return on equity of 37.90%. The business had revenue of $62.30 million for the quarter, compared to analysts’ expectations of $60.58 million. During the same quarter last year, the company posted ($0.10) EPS. The company’s revenue was up 18.0% compared to the same quarter last year. Research analysts expect that Paragon 28, Inc. will post -0.66 earnings per share for the current year.

Insider Buying and Selling at Paragon 28

In other Paragon 28 news, major shareholder Mvm Partners, Llc sold 72,133 shares of the firm’s stock in a transaction dated Friday, November 22nd. The stock was sold at an average price of $10.16, for a total value of $732,871.28. Following the completion of the sale, the insider now owns 10,559,065 shares of the company’s stock, valued at approximately $107,280,100.40. This trade represents a 0.68 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders have sold 252,914 shares of company stock valued at $2,585,514 in the last quarter. 15.32% of the stock is owned by insiders.

Analyst Ratings Changes

A number of research firms recently issued reports on FNA. Needham & Company LLC increased their price target on shares of Paragon 28 from $11.00 to $13.00 and gave the stock a “buy” rating in a research note on Wednesday, November 13th. Canaccord Genuity Group dropped their price target on shares of Paragon 28 from $17.00 to $15.00 and set a “buy” rating on the stock in a research note on Wednesday, November 13th. Finally, Stephens upgraded shares of Paragon 28 to a “strong-buy” rating in a research note on Monday, December 2nd. Four analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of $15.60.

Paragon 28 Profile

Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.